Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines

• 2023

  Log in to bookmark this resource.

  Log in
• Sean O'Leary; Alexandra Yonts; Claudia Gaviria-Agudelo; David Kimberlin; Grant Paulsen
PMID: 37641189DOI: https://doi.org/10.1542/peds.2023-063955

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article describes updates from the Advisory Committee on Immunization Practices (ACIP) about vaccines for children. It highlights new recommendations for using nirsevimab, a monoclonal antibody, to prevent RSV in infants. The ACIP also discussed changes to pneumococcal and meningococcal vaccine guidelines and reviewed influenza vaccination advice, especially for those with egg allergies. Additionally, it covers ongoing studies on COVID-19 vaccines and safety concerns related to childhood immunizations. The updates aim to improve vaccine effectiveness and address public health needs while ensuring safety in pediatric populations.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Immunization; Immunization Schedule; Infant; Influenza Vaccines; Respiratory Syncytial Viruses; Vaccination; Advisory Committees; Immunization Programs; Pneumococcal Vaccines; Meningococcal Vaccines; Antibodies, Monoclonal, Humanized; COVID-19 Vaccines

Institutions: University of Colorado; Children's National Hospital; University of South Florida; University of Alabama at Birmingham; University of Cincinnati; Cincinnati Children's Hospital Medical Center

---

More like this

Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines 2024 · Children's National Hospital, University of South Florida, University of Alabama at Birmingham, University of Colorado, University of Cincinnati Postacute Sequelae of SARS-CoV-2 in Children 2024 · Children's Hospital Colorado, New York University, Children's Hospital Los Angeles, University of Southern California, Children's Hospital of Philadelphia, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Nemours Children's Health, Columbia University, Ann and Robert H. Lurie Children’s Hospital, University of California, San Diego Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024 2024 · Centers for Disease Control and Prevention (CDC), U.S. Public Health Service, University of Rochester, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Vanderbilt University, Texas Children's Hospital, Baylor College of Medicine, University of Washington, University of Pittsburgh, Children's Mercy Kansas City

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---